Gregory S. Knight

Gregory S. Knight serves as a Contract Specialist responsible for managing the full lifecycle of federal acquisitions, from requirements validation through contract award and administration. He plays a critical role in ensuring compliance with the Federal Acquisition Regulation (FAR) while supporting mission-critical procurements for medical and diagnostic equipment. His portfolio primarily involves complex, technical acquisitions requiring detailed market research, source selection, and contract negotiation, with a strong emphasis on ensuring regulatory adherence and timely delivery of essential healthcare technologies. Knight’s contracting patterns reflect a preference for open, non-set-aside competitions, with 94.1% of awards issued under unrestricted solicitations. While small business participation is limited in volume, he consistently leverages Total Small Business Set-Asides under FAR 19.5, demonstrating a measured but intentional commitment to fostering competition among qualified small vendors. He does not appear to routinely utilize specialized socioeconomic programs such as 8(a), HUBZone, or SDVOSB set-asides, instead prioritizing broad-based small business eligibility under general small business criteria. His procurement focus centers on high-precision medical manufacturing sectors, with primary emphasis on NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing), 339112 (Surgical and Medical Instrument Manufacturing), and 339113 (Surgical Appliance and Supplies Manufacturing). He regularly acquires specialized laboratory reagents, diagnostic kits, surgical tools, and electromedical devices, requiring deep technical understanding of FDA-regulated products and quality control standards. His expertise extends to navigating the intersection of clinical needs and manufacturing compliance, ensuring procurements align with both operational requirements and federal procurement integrity standards.